Here, we have analyzed and compared the CD8+ T-cell response to SARS-CoV-2 infection in severe COVID-19 patients and in vaccinees that received mRNA-based vaccines (BNT162b2 from Pfizer/BioNTech and mRNA-1273 from Moderna). This evidence concerns the gene CD8A and COVID-19.